רווח למניה בשנים עשר החודשים האחרונים: Notable Labs Ltd (NTBL)
Notable Labs, Ltd. (NTBL) faces a liquidity shortage and a dependence on external financing due to high IT development costs. Growth is hindered by complexities in implementing the system within clinics and potential insurance denials. The EPS trend over the last 12 months, where the indicator reaches -1.09, illustrates the dynamics of the company, which created a unique therapy selection method via live-cell testing.
פילוחים אנליטיים ודוחות נתונים של חברת Notable Labs, Ltd. (NTBL)
Annual earnings per share measures the portion of actual income attributable to a single security. Growth in this ratio confirms capital management efficiency and the fundamental stability of the business. By analyzing the trend of the rolling annual EPS, an investor determines the degree of overpayment for the asset. For Notable Labs, Ltd. (NTBL), profit dynamics depend directly on the cost of external substance synthesis. The absence of proprietary plants makes this indicator sensitive to the pricing power of outsourcing laboratories.
